| SPAIN | WP5 | |||
| Organization | UNIOVI | |||
| Name of cohort | ORCHESTRA UNIOVI | |||
| Referring partner | UNIOVI | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | Oviedo, Asturias, Spain | ||
| Time of data collection | 05/2020 | 05/2024 | ||
| Enrolment | Inactive | |||
| Study setting | Multi-centers | |||
| Population | Age | Adults | ||
| Type | Prospective | |||
| Total number of patients | 8230 | |||
| Data collection | Clinical data | False | ||
| Serological data | False | |||
| Genetic data | False | |||
| Sample collection | False | |||
| Sample collected | Whole blood | NA | ||
| PBMC | NA | |||
| Dry-spot blood | NA | |||
| Plasma | NA | |||
| Serum | NA | |||
| Stool | NA | |||
| NP swabs | NA | |||
| Other | NA | |||
| Description | The University of Oviedo is the main engine of research in Asturias. It develops 80% of the R + D + i of the autonomous community and has cutting-edge services and equipment to facilitate the transfer of knowledge to the productive fabric. The income derived from scientific production is estimated at about 40 million euros per year and has more than 500 contracts and / or agreements with companies to develop research projects and knowledge transfer. | |||
| Publications |
- SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers [Vaccines] - Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay [Frontiers in Immunology] | |||